靶向 EpCAM 和诱导型 ICAM-1 的双特异性 CAR-T 细胞克服抗原异质性并产生更优抗肿瘤反应
Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses.
46.9分
★★★☆☆
站内排序·非疗效
FRONTIER PAPERS
Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses.
共 1 条
MEMBER ACCOUNT
登录成功会直接打开下一页。